Search results
Study suggests hepatitis E may be a sexually transmitted infection
Medical Xpress· 6 days agoHepatitis E (HEV) is the leading cause of the acute viral liver infection in humans worldwide,...
Drinking water recall becomes "nightmare" after 5-year-old hospitalized
Newsweek· 5 days agoA mother whose child suffered liver damage from toxic chemicals in a bottled water brand has called...
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for...
Morningstar· 4 days agoGilead Sciences, Inc. (Nasdaq: GILD) today announced topline results from an interim analysis of its pivotal, Phase 3 PURPOSE 1 trial indicating that the company’s twice-yearly injectable HIV ...
Pushing Medical Boundaries in Fight Against COVID-19
New Jersey Business Magazine· 4 hours agoThe state’s ongoing efforts to advance medical technology and healthcare delivery hold new relevance in the treatment of diseases such as COVID-19....
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including...
FOX 23 News Albany· 6 days agoPharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today ...
Gaza: A mother's desperate plea to feed her baby
BBC via Yahoo News· 6 days agoHe warned that the lack of health services, clean water and sanitation “significantly increases the risk of malnourished children". The situation means...
Plaintiffs awarded nearly $3.1B in Real Water lawsuit
KSNV 3 Las Vegas· 7 days agoA jury awarded plaintiffs nearly $3.1 billion against the maker of Real Water for suffering liver...
H2Ozarks’ septic programs offered to area residents
Branson Tri-Lakes News· 6 days agoArea homeowners with a failing septic system may qualify for 100% reimbursement on repairs.
Live from EHA 2024 | Ascentage Pharma Releases Updated Data of Lisaftoclax in Patients with R/R MM...
FOX 23 News Albany· 6 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ...
The fight over taxing health insurance
Politico· 7 days agoCBO’S HEP C ASK — The Congressional Budget Office is calling for research on the costs of treating hepatitis C and the effectiveness of testing and treatment efforts. Millions ...